News Daily News Online Calculator Allows Young Adults to See How Their 30-Year CV Risk Compares to Peers’ Yael L. Maxwell November 19, 2025
News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025
News Conference News TCT 2025 Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION Michael O'Riordan October 26, 2025
News Daily News European Experts Provide Advice on Managing CV Effects of COVID-19 Todd Neale September 19, 2025
News Conference News ESC 2025 BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension Todd Neale August 31, 2025
News Daily News AI-Supported Coaching Shows Promise for Improving Glycemic Control L.A. McKeown August 25, 2025
News Opinion Editor's Corner ESC 2025 What’s Going to Be Hot at ESC Congress 2025? Michael O'Riordan August 25, 2025
News Daily News New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists Yael L. Maxwell August 14, 2025
News Conference News SCCT 2025 Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges Yael L. Maxwell July 25, 2025
News Daily News Baxdrostat Shows Promise in Uncontrolled or Resistant Hypertension L.A. McKeown July 14, 2025
News Daily News Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy Caitlin E. Cox April 14, 2025
News Daily News Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis Yael L. Maxwell February 27, 2025
News Daily News Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study Yael L. Maxwell February 20, 2025
News Daily News Early Actions by Trump Administration Sow Uncertainty for CV Research Todd Neale January 30, 2025
News Opinion Editor's Corner TCTMD’s Biggest News of 2024: Stories, Videos, and More Shelley Wood January 01, 2025